http://www.fpnotebook.com/
Cialis
Aka: Cialis, Tadalafil
- Indications
- Psychogenic Impotence
- Neurogenic Impotence
- Vasculogenic Impotence
- Contraindications
- Absolute Contraindications (risk of Hypotension)
- Men using nitrates (i.e. Nitroglycerin)
- Men using alpha blockers (e.g. Hytrin for BPH)
- Relative Contraindications
- Active coronary ischemia in men not on nitrates
- Congestive Heart Failure
- Borderline low Blood Pressure
- Bordrline low volume status
- Multidrug antihypertensive regimen
- Taking Cytochrome P450-3A4 (CYP3A4) inhibitor
- Mechanism
- Phosphodiesterase Type 5 causes Erection to subside
- Cialis blocks Phosphodiesterase Type 5
- Results in enhanced Erection if man is aroused
- Unlike Alprostadil, will not cause Erection
- Cialis enhances vasodilating effect of Nitrous Oxide
- Normally released during sexual stimulation
- Pharmacokinetics
- Onset within 30 to 60 minutes
- Duration as long as 36 hours
- Contrast with 4 hours with Viagra
- Prolonged effect also leads to prolonged side effects
- Dosing
- Start 20 mg PO 1 hour before intercourse
- Do not take more than once per 2 days
- Most insurance limits to 6 per month
- Indications to start with half dosing (10 mg)
- Age over 65 years
- Hepatic Impairment
- Renal Impairment
- Concurrent use of Cytochrome P3A4 inhibitor below
- Drug Interactions
- Inhibit breakdown of Viagra via Cytochrome P3A4
- Cimetidine (Tagamet)
- Erythromycin
- Ketoconazole (Nizoral)
- Itraconazole (Sporonox)
- Mibefradil (Posicor)
- Profound Vasodilitation and Hypotension (Avoid)
- Nitrates
- Alpha-blockers (use Tamsulosin instead)
- Uroxatral
- Doxazosin
- Terazosin
- Prazosin
- Adverse Effects
- Hypotensive effect for men on Nitrates (Avoid)
- Temporary color vision disturbance
- Blue colors may appear to be green
- Mild Headache
- Facial Flushing
- Myalgias
- Indigestion or Dyspepsia
- Does not cause Priapism
- Sensorineural Hearing Loss
- Sudden onset and permanent Hearing Loss
- McGwin (2010) Arch Otolaryngol Head Neck Surg 136(5):488-49
- References
- 2003 Med Lett Drug Ther 45:101-2